Director, President, CEO · First Tracks Biotherapeutics, Inc. · First Tracks Biotherapeutics, Inc. — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
9,200
Price
—
Executed
Apr 20, 2026
Disclosed
Apr 22, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 20 executedApr 22, 2026 disclosed
TRAX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
First Tracks Biotherapeutics, Inc. — Employee Stock Option (right to buy)
Ticker
TRAX
Shares
9,200
Price per share
$0
Execution date (reported)
Apr 20, 2026
Owned after transaction
9,200 shares
Days from execution to publication
2
What this establishes
Faga Daniel filed this Form 4 reporting a grant or award of TRAX on Apr 20, 2026. It became public on Apr 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President, CEO
Faga Danielcik:0001673528
Issuer
First Tracks Biotherapeutics, Inc.cik:0002091349
Revision history · 0
No field has changed since this record was first ingested.
